Procaps Group to acquire Grupo Somar from Advent International, gaining an important presence in Mexico, the region´s second largest market

MIAMI, USA – BARRANQUILLA, COL – May 17, 2022 – Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it has entered into a definitive agreement to acquire Grupo Somar (including Grupo Farmacéutico Somar and Química y Farmacia and, Gelcaps and related entities) from Advent International (“Advent”), one of the world’s largest private equity investors. Grupo Somar is an integrated pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded generic, private label and OTC products targeted to the private market and offering CDMO services across key market segments in Mexico. Grupo Somar offers a diversified portfolio of products across key categories and has strong R&D and manufacturing capabilities, operating six modern production facilities (two of which […]

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related

The roadmap for new policy-making: a conversation with the Executive Secretary of ECLAC. 

Although unthinkable, the pandemic brought something good. “It moved...

Products and sustainability: The plans of Coca-Cola’s President of Latin America

This year, Coca-Cola introduced to Latin America a beverage...

Be ready to watch Venezuela’s resurrection

Restaurants in Caracas are full and it is hard...